Tagged with free

Pharma ResMed MD, Lucile Blaise, explains the medical device company’s focus on delivering data informatics and analytics to patients with sleep-related diseases and disorders in the comfort of their own homes. Very few doctors realize the dangers of sleep apnea, often referred to as a “silent killer.” ResMed is unique in…

Pharma János Burovincz, Managing Director of Patent, shares his insights on building a company from scratch, the importance of maintaining a diverse portfolio that can quickly adapt to market needs as well as his priorities going forward to continue growing the company’s footprint in Hungary. He also discusses the company’s strong…

Pharma Global skin care leader Beiersdorf is investing in developing their pharmacy channel and Gaetano Colabucci, managing director of Beiersdorf Italy, explains the importance the Internet plays in patient education and product accessibility as well as highlighting the role regional insights can play in the development of global products. When you…

Pharma Biotest France’s Olivier Samama discusses their recent re-entry into France, their focus on homecare treatment, and their expertise in fractionation and plasma derived products. What are the objectives and goals you have been given by Dr Bernhard Ehmer and what exactly has happened in building this affiliate these last two…

Pharma Having led a successful turnaround of the affiliate in just eight months, Nadia Cortesi of ResMed explains how she has achieved double digit growth, while facing sustained external challenges, including low awareness among consumers and healthcare authorities of the potential complications that sleep pathologies can cause. Can you please introduce…

Pharma GSK Hungary’s Claire Roger discusses the value of ethical promotion both in improving transparency and benefiting all stakeholders. She further describes the strategic role and economic impact of GSK’s vaccine plant in Gödöllő and growth opportunities in HIV. Given that you’ve only recently arrived in May 2015, Claire, what priorities have been at the…

Pharma Sébastien Lucot, General Manager of Uriage, explains the company’s product base, their line of thermal water based products and the healing properties of Uriage water from the French Alps. Lucot expands on Uriage’s growing presence in France, Europe and Asia as well as their new branding strategy to grow their…

Pharma Despite the already existing efficiencies in the Italian healthcare system, there is still significant room for improvement. Johnson & Johnson Medical’s head for southern Europe discusses a number of opportunities where the company can help to improve healthcare quality while reducing costs holistically. Given Italy’s current healthcare sustainability concerns, what…

Pharma 3PL player BOMI Group went public via an IPO in June 2015. VP & CFO Marco Ruini discusses the reasons behind this Italian family company’s decision to go public, as well as its ambitious expansion strategy. How would you assess the success of the IPO that took place last year? This IPO…

Pharma Róbert Ésik, President of the Hungarian Investment Promotion Agency (HIPA), shares his insights into what makes Hungary such an attractive destination for foreign direct investment and ways that the agency will work to increase the amount of FDI in the country. He also discusses the unique Hungarian business culture and…

Pharma Veronika Ferencz, Sales and Marketing Director for Exeltis Hungary, discusses the evolving and expanding footprint of the company in Hungary, the challenges strict regulations on food supplements are causing, as well as the need for better recognition of women’s health as a therapeutic area. She also reflects on her own…

Pharma The leadership of Meditop discuss their history as the first non-privatized, private Hungarian pharmaceutical company, their ongoing strategies for growth in the country, and their evolving portfolio abroad. They also discuss the complexities of the Hungarian healthcare and pharmaceutical market and give an overview of their past challenges and current…